GlaxoSmithKline (LSE:GSK)
GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.
{{ formattedPrice }} {{ change }} (3.11%)
Quotes delayed. Last trade: 19-10-2018, 04:37:41pm BST
| Open Price | {{ openPrice }} | Close Price | {{ closePrice }} |
| Day High | {{ high }} | Day Low | {{ low }} |
| Bid | {{ bid }} | Ask | {{ ask }} |
| Volume | 10655651 |
Related Articles
-
Forget cash ISAs! Why bother when you can get 5.5% a year from investing in the GSK share price
Harvey Jones says that FTSE 100 (INDEXFTSE: UKX) pharmaceutical giant GlaxoSmithKline plc (LON: GSK) pays around six times the income you will get from... Read More »
-
Is the GlaxoSmithKline share price a bargain or should I buy this high-yielding small-cap?
Does this small-cap share’s recovery potential outshine the forward prospects of GlaxoSmithKline plc (LON: GSK)? Read More »
-
GSK and Sopheon’s share prices have beaten the FTSE 100 by 20%, is it time to buy?
Do GlaxoSmithKline plc (LON: GSK) and Sopheon plc (LON: SPE) offer further FTSE 100 (INDEXFTSE: UKX) outperformance potential? Read More »
-
Is this FTSE 250 faller set to bounce back and crush the GSK share price?
The GlaxoSmithKline plc (LON: GSK) share price has climbed in 2018, but here's one that could beat it in 2019. Read More »
-
FTSE 100 dividend stock GlaxoSmithKline isn’t the only healthcare star that could help you retire rich
Royston Wild explains why GlaxoSmithKline plc (LON: GSK) is just one London-quoted healthcare stock that could make you rich. Read More »
-
GlaxoSmithKline isn’t the only way to profit from the world’s ageing population
Edward Sheldon looks at a stock which, alongside GlaxoSmithKline plc (LON: GSK), could be set to benefit from the explosion in retirees across the... Read More »
-
3 FTSE 100 dividend stocks yielding 5%+ I’d buy for a new SIPP
Roland Head reveals his three top FTSE 100 (INDEXFTSE:UKX) picks for a starter pension portfolio. Read More »
-
Is the GSK share price primed to beat the FTSE 100?
Could GlaxoSmithKline plc (LON: GSK) deliver stronger total returns than the FTSE 100 (INDEXFTSE: UKX)? Read More »
-
GlaxoSmithKline isn’t the only pharmaceutical share I’d buy right now
Why I’m tempted by GlaxoSmithKline plc (LON: GSK) and this fast-growing pharmaceutical firm. Read More »
-
Two dirt-cheap FTSE 100 high-yield stocks for bargain hunters
Want to beat the FTSE 100's (INDEXFTSE: UKX) average dividend yield? Consider these near-5%-yielding, bargain-basement shares. Read More »
